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Successful encapsidation of hepadnaviral pregenomic RNA requires the orchestrated interaction of the viral capsid and
polymerase proteins with each other and with the RNA packaging substrate. The early steps of this process involve binding
of the polymerase to the encapsidation signal, e, and are already understood in some detail. However, the underlying
macromolecular interactions resulting in the subsequent encapsidation of this polymerase–e complex by capsid proteins
are less clearly defined. To approach this issue we have examined the ability of two different hepadnaviruses to encapsidate
each other’s pregenomic RNA. H. Okamoto et al. ((1990) J. Gen. Virol. 71, 959–963) have previously demonstrated that WHV
polymerase could encapsidate an HBV pregenome, but the origin of the capsid proteins (i.e., HBV- or WHV-derived) required
for this reaction was not clear; some evidence suggested that heterologous capsid and polymerase proteins might not be
capable of interaction. To clarify this, we analyzed encapsidated RNA isolated from cytoplasmic cores produced following
transient transfection of HepG2 cells with different combinations of plasmids encoding HBV or WHV core and polymerase
genes. We found that (i) the essential encapsidation signal of WHV is comprised of a short region including e, as in HBV;
(ii) HBV and WHV polymerases are each competent to recognize both HBV and WHV packaging signals; therefore the
encapsidation signals are functionally interchangeable; and (iii) HBV capsids encapsidate a WHV polymerase–e complex,
and vice versa, although the efficiency of heterologous packaging is slightly lower than that of homologous encapsidation.
Our results underscore the close relationship of these two mammalian hepadnaviruses. q 1996 Academic Press, Inc.
INTRODUCTION complement of envelope glycoproteins. The result is the
formation of mature virions within the secretory pathway,
All hepatitis B viruses (hepadnaviruses) replicate their from which they are secreted by constitutive vesicular
DNA genomes by reverse transcription of an RNA inter- transport (for a recent review see Ganem, 1996).
mediate (Summers and Mason, 1982). Virions contain The prototype of the hepadnaviruses is human hepati-
an outer envelope composed of several lipid-associated tis B virus (HBV), which is strongly associated with liver
surface glycoproteins; internal to this is the viral nucleo- cancer. Of the other mammalian members of this family,
capsid (core), an icosahedral structure made up of 180 woodchuck hepatitis virus (WHV), which causes similar
or 240 subunits of the capsid protein. Within the core disease in woodchucks, is the most intensively studied.
is the viral genome, a partially duplex, relaxed circular The DNA genomes of these two viruses are about 60%
molecule of ca. 3 kb and a polymerase centrally involved identical (Kodama et al., 1985). In vivo packaging assays
in genomic replication. Core particles form in the cyto- allowed for a detailed delineation of the extent of the
plasm; in so doing they selectively encapsidate pregeno- HBV encapsidation signal (Junker-Niepmann et al., 1990;
mic RNA and polymerase. The encapsidation signal on Chiang et al., 1992; Pollack and Ganem, 1993). These
pregenomic RNA harbors a stem–loop structure at its 5* studies demonstrated that a short RNA region including
end, designated e (Junker-Niepmann et al., 1990; Pollack the 5* e is sufficient to direct encapsidation of heterolo-
and Ganem, 1993). Recent work has directly demon- gous RNA. Interestingly, the encapsidation signal of duck
strated binding of polymerase to the encapsidation sig- hepatitis B virus (DHBV) requires two discontinuous re-
nal in vitro (Pollack and Ganem, 1994; Wang et al., 1994). gions in cis; in addition to e a second region about 900
Once the RNA has been encapsidated, reverse transcrip- nt downstream is necessary for RNA packaging (Hirsch
tion begins; this reaction is primed by polymerase on a et al., 1991; Calvert and Summers, 1994). The WHV en-
template composed of the e stem–loop, resulting in a capsidation signal and the parameters that govern WHV
protein-linked DNA product (Wang and Seeger, 1992). pregenome encapsidation have not been well defined;
Following DNA synthesis, nucleocapsids containing the in particular, little is known of the events occuring follow-
mature DNA genome bud into the ER, picking up their ing the formation of the polymerase–RNA complex. To
investigate these steps in more detail, we examined the
ability of HBV and WHV capsid and polymerase proteins
1 To whom correspondence should be addressed. Fax: (415) 476- to functionally interact with each other during RNA pack-
0939. E-mail: ganem@socrates.ucsf.edu.
aging.
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MATERIALS AND METHODS Cell culture and transfections
The human hepatoma cell line HepG2 was utilized inViral strains and plasmids
our experiments. Cells were grown in HME16 medium
supplemented with 10% fetal calf serum, 2 mM glutamine,HBV DNA used in this study is from strain HBVadw2
100 mg/ml streptomycin, and 100 units/ml penicillin, and(Valenzuela et al., 1980), and WHV sequences originated
were passaged every 3 to 4 days at a 1:4 dilution. Trans-from an infectious isolate that replicates well in HepG2
fections with purified plasmid DNA were carried out ascells and is most closely related to WH81 (Kodama et al.,
described previously, using the calcium phosphate co-1985). In both viruses nucleotide positions are numbered
precipitation method (Hirsch et al., 1988). Cells were atfrom the unique EcoRI sites.
about 30–35% confluency (ca. 2 1 106 cells total per
All donor plasmids which encode viral capsid and/or
dish) when transfected.
polymerase proteins are derivatives of pcDNAIII (In-
vitrogen, U.S.A.). pHBV-CP has a ca. 3.4-kb StyI (nt 1880)
RNA preparation and Northern blot analysis
to TaqI (nt 2012) HBV fragment inserted downstream of
the cytomegalovirus (CMV) immediate-early promoter; in Poly(A)/ selected total-cell RNA and RNA isolated from
addition it carries the env0 mutation in gene S (Bruss cytoplasmic cores were purified ca. 70 hr after transfec-
and Ganem, 1991). pHBV-CPDe is derived from pHBV- tion, essentially as described by Pollack and Ganem
CP; it has the ca. 210-bp FspI (nt 1800) to TaqI (nt 2012) (1993). One-third of RNA samples each harvested from
e bearing fragment deleted. pHBV-C1 was constructed approximately equivalent numbers of transfected cells of
by linearization of pHBV-CP with BstEII (nt 2819), subse- one 100-mm dish were separated on a 1% agarose gel
quent treatment with Klenow polymerase to make blunt containing 2.2 M formaldehyde and subsequently trans-
ends, followed by religation using T4 DNA ligase. This ferred to a Hybond N membrane (Amersham, U.S.A.).
created a 4-bp insertion resulting in a frameshift in the Prehybridization and hybridization were carried out ac-
5*-region of the polymerase gene. To generate pHBV-C2 cording to standard procedures (Maniatis et al., 1982). A
we linearized pHBV-CP with XcmI (nt 691), treated with ca. 2.55-kb random-primed lacZ gene PvuII fragment was
T4 DNA polymerase, and religated. Two base pairs were used as hybridization probe.
deleted by this procedure, again causing a frameshift
but now in the 3*-region of the polymerase gene. pHBV-P RESULTS AND DISCUSSION
carries the TaqI (nt 2012) to TaqI (nt 2012) HBV monomer
Sequence requirements for HBV and WHVfragment and the env0 mutation in gene S (Bruss and
pregenome encapsidation are similarGanem, 1991).
pWHV-CP carries a ca. 3.5-kb StyI (nt 2002) to HindIII To analyze the WHV encapsidation signal we em-
(nt 2190) WHV fragment. The ca. 410-bp SphI (nt 1776) ployed an in vivo encapsidation assay similar to that
to HindIII (nt 2190) fragment is deleted in its derivative described previously (Pollack and Ganem, 1993). In this
pWHV-CPDe. To generate pWHV-C1, we linearized assay, the ability of capsid and polymerase proteins
pWHV-CP with PacI (nt 2815), treated then with T4 DNA translated from a message lacking the 5* e to package
polymerase, and religated. This caused a 2-bp deletion a heterologous RNA molecule bearing the viral encapsi-
resulting in a frameshift in the 5*-region of the polymer- dation signal is measured. Donor plasmids pHBV-CP and
ase gene. pWHV-C2 was made by linearization of pWHV- pWHV-CP encode the capsid and polymerase proteins
CP with PflMI (nt 1334), subsequent treatment with T4 of HBV and WHV, respectively (Fig. 1A). Both plasmids
DNA polymerase, and religation. Four base pairs were lack the 5* e required for encapsidation and hence cannot
deleted, causing a frameshift in the 3*-region of the poly- lead to packaging of their respective transcripts, but they
merase gene. In order to generate pWHV-P we linearized do contain the 3* e. As a source of packaging substrate
pWHV-CP with AflII (nt 2303), followed by treatment with we used pE-LacZ, a plasmid described earlier which gen-
Klenow polymerase and religation. Two base pairs were erates a chimeric HBV e-lacZ transcript (Fig. 1B; Pollack
inserted, thus causing truncation of the capsid protein and Ganem, 1993). In addition, we constructed two plas-
due to premature termination two amino acids down- mids bearing the WHV e region upstream of lacZ. Tran-
stream of the now destroyed AflII restriction site. scription from pWHV-e-1 (Fig. 1B) results in a mRNA start-
Recipient plasmid pE-LacZ (Pollack and Ganem, 1993) ing at nt 1912 of the WHV genome, thus destroying the
generates an HBV e-lacZ chimeric RNA which serves as ATG of the first precore start codon (nt 1912 being the
packaging substrate. The HBV e part in pE-LacZ is re- G in this start codon; Fig. 1C); Seeger et al. (1989) have
placed by a 281-bp WHV e fragment (from nt 1912 to shown earlier that pregenome encapsidation is impaired
2192) in pWHV-e-1, and by a 243-bp WHV e fragment when precore protein is synthesized from a mRNA which
(from nt 1950 to 2192) in pWHV-e-2. includes this start codon. HepG2 cells were transfected
All cloning junctions and individual mutations were with these plasmids in the combinations indicated in Fig.
2A. Three days after transfection poly(A)/ RNA and RNAverified by DNA sequencing (Sanger et al., 1977).
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from within cytoplasmic cores were prepared and ana-
lyzed by Northern blotting. Levels of total cellular poly(A)/
RNA are comparable in each set of transfections (com-
pare lanes 1, 3, 5, and 7 in Fig. 2A). As can be seen in
lanes 2 and 6, when cotransfected with pE-LacZ, pHBV-
CP and pWHV-CP encode proteins which encapsidate
the HBV e-lacZ message efficiently; we estimate that up
to 50% of all transcripts are packaged. However, upon
cotransfection with pWHV-e-1 (Fig. 2A, lanes 4 and 8),
encapsidation occurs very poorly. Inspection of the WHV
DNA sequence reveals that WHV precore contains a sec-
ond in-frame ATG (Fig. 1C; Mo¨ro¨y et al., 1985); if this
codon were active as an initiator, it could lead to transla-
tional interference with RNA packaging, as has been pre-
viously documented for HBV (Junker-Niepmann et al.,
1990; Nassal et al., 1990). Therefore we designed and
tested another plasmid, pWHV-e-2 (Fig. 1B), where tran-
scription initiates at nt 1950 within DR1, downstream of
both precore start codons (Fig. 1C). Both HBV (Fig. 2B,
lanes 1 and 2) and WHV (lanes 3 and 4) viral proteins
encapsidate the pWHV-e-2 message efficiently. These
experiments confirm and extend earlier results of Oka-
moto et al. (1990), demonstrating that HBV and WHV
proteins can recognize and encapsidate either viral pre-
genome. Furthermore, the WHV encapsidation signal
consists of only one short region including e, as is the
case for HBV, reflecting the closer relationship of WHV
to HBV than to DHBV. We also suggest that ribosomal
interference likely prevents efficient encapsidation of the
WHV precore mRNA, as in HBV (Junker-Niepmann et al.,
1990; Nassal et al., 1990), and can operate from the inter-
nal, downstream precore AUG as well as from the first,
upstream initiator codon.
e is not required in cis for the packaging activity of
polymerase
It is known that the 3* copy of e is not required for
generating enzymatically active DHBV polymerase in
vitro (Pollack and Ganem, 1994; Wang et al., 1994), nor
is it necessary in cis for WHV (Seeger and Maragos,
1990) or HBV (Rieger and Nassal, 1996) replication; but
in the latter two reports the 5* copy of e was still present
FIG. 1. Schematic representation of constructs encoding HBV or on each viral pregenome. In fact, in all previous studies
WHV capsid and polymerase proteins (A), and HBV or WHV e-lacZ
in which trans-acting hepadnaviral polymerase was pro-chimeric RNAs (B). In (A), S and X genes were omitted for clarity. Open
duced in vivo, it has been generated from a mRNA con-boxes depict genes or cis-acting sites and dashed boxes indicate loss
of gene function due to mutation. If present, the 3* copy of e is denoted taining a copy of e in cis (Chiang et al., 1990; Hirsch et
by the letter e in (A). With the exception of pHBV-CPDe and pWHV- al., 1990; Junker-Niepmann et al., 1990; Okamoto et al.,
CPDe, which bear only the pcDNAIII-derived bovine growth hormone 1990; Schaller and Radziwill, 1990; Hirsch et al., 1991;
gene polyadenylation signal, all other plasmids in (A) additionally har-
Chiang et al., 1992; Pollack and Ganem, 1993). Tavisbor virus-derived polyadenylation sites. Construction of plasmids and
and Ganem (1993) described a system utilizing the TY1exact extents of viral inserts are described under Materials and Meth-
ods, and pE-LacZ is described in Pollack and Ganem (1993). In (C), retrotransposon, where enzymatically active DHBV poly-
the WH81 nucleotide sequence from position 1900–1960 is given. The merase was successfully expressed in and purified from
first and second precore start codons at nt 1910–1912 and nt 1931– yeast cells. This activity is strictly dependent on the poly-
1933, respectively, are indicated by bold letters. The underlined region
merase expression vector harboring a copy of e in cisrepresents DR1, and position 1950 identifies the start site of transcrip-
(J. E. Tavis and D. Ganem, unpublished observations).tion in pWHV-e-2. The arrow at nt 1934 denotes the 5* end of pregeno-
mic RNA (Seeger et al., 1989). Furthermore, using the recombinant baculovirus system,
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FIG. 2. HBV and WHV proteins each encapsidate HBV- and WHV-derived e-lacZ chimeric RNAs. Northern blot analysis of RNA isolated from
transfected HepG2 cells. 100-mm dishes of cells were cotransfected with 10 mg each of the plasmids indicated above the lanes. Lanes 1, 3, 5, 7,
total poly(A)/-selected RNA; lanes 2, 4, 6, 8, RNA isolated from purified cytoplasmic cores. One-third of the total RNA harvested from one dish was
loaded in each lane. The major band in all lanes corresponds to a e-lacZ chimeric RNA molecule of approximately 3.5 kb in length. Larger bands
in lanes 1, 3, 5, and 7 most likely represent read-through RNAs. In (A), pE-LacZ and pWHV-e-1 were used as recipient plasmids; in (B), pWHV-e-2
was cotransfected with the donor plasmids indicated.
Lanford et al. (1995) reported recently that enzymatically HepG2 cells were cotransfected with plasmids harboring
dimers of a polymerase-negative HBV and a wild-typeactive HBV polymerase could be purified reproducibly
from insect cells only when its mRNA contained a cis- WHV genome. In that study, the nature of viral DNA iso-
lated from secreted virions was analyzed by Southerncopy of e. These data might indicate a cis-requirement
for at least one copy of e to assist directly or indirectly hybridization. However, in their experiment it is unclear
whether the WHV polymerase–HBV pregenome complexin the correct folding of the polymerase chain during
translation in vivo. To learn whether there is a require- was encapsidated by HBV or WHV (or both) capsid pro-
teins. Importantly, no such complementation of capsidment for a cis-copy of e in our encapsidation system,
function was observed when the HBV genome carriedwe constructed pHBV-CPDe and pWHV-CPDe (Fig. 1A),
a mutation in the core gene (the complementing WHVwhich are derived from pHBV-CP and pWHV-CP, respec-
genome again being wild type). These results raised thetively, and carry no copy of e. We compared the packag-
ing efficiencies of these plasmids with those of their
respective parent plasmids in our standard packaging
assay. Figure 3 shows that there is no difference detect-
able in our system (compare lanes 1 and 2 with lanes 3
and 4, and lanes 5 and 6 with lanes 7 and 8). Hence, we
find no cis-requirement for e for encapsidation. If e is
required for activation of P protein, it clearly can be sup-
plied in trans. When interpretating this result one should
consider that while a full-length polymerase is required
for encapsidation, none of the enzymatic properties of
this protein (i.e., priming, reverse transcription, and
RNaseH function) are necessary for this activity (Bar-
tenschlager et al., 1990; Chang et al., 1990; Hirsch et al.,
1990). Unlike the experiments described by Lanford et
al. (1995) our studies examine RNA encapsidation only,
and thus do not exclude the possibility that e might be
required in cis to activate polymerase replication func-
FIG. 3. Packaging competent polymerases need not be synthesized
tions in vivo. from a template containing a cis-copy of e. Northern blot analysis of
RNA isolated from transfected HepG2 cells. 100-mm dishes of cells
Homologous and heterologous complementation in were cotransfected with 10 mg each of the plasmids indicated above
RNA packaging the lanes. Lanes 1, 3, 5, 7, total poly(A)/ selected RNA; lanes 2, 4, 6,
8, RNA isolated from purified cytoplasmic cores. The major band in all
Okamoto et al. (1990) reported weak complementation lanes corresponds to a e-lacZ chimeric RNA molecule of approximately
3.5 kb in length.of HBV polymerase function by its WHV homolog, when
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FIG. 4. Trans-complementation of capsid and polymerase functions. Northern blot analysis of RNA isolated from transfected HepG2 cells.
(A) Homologous complementation of HBV encapsidation functions. Lanes 1–6, 10 mg each of the plasmids indicated above these lanes were
cotransfected; lanes 7 and 8, 5 mg pHBV-C1/ 5 mg pHBV-P/ 10 mg pE-LacZ were cotransfected. (B) Homologous and heterologous complementation
of hepadnaviral encapsidation functions. Lanes 1 and 2, 10 mg of each indicated plasmid were cotransfected; lanes 3–8, 5 mg of each of the two
donor plasmids and 10 mg of the pWHV-e-2 recipient plasmid were cotransfected. (C) Homologous complementation of WHV encapsidation functions.
Lanes 1–6, 10 mg each of the plasmids indicated above these lanes were cotransfected; lanes 7 and 8, 5 mg pWHV-C1 / 5 mg pWHV-P / 10 mg
pE-LacZ were cotransfected. (D) Homologous and heterologous complementation of hepadnaviral encapsidation functions. Lanes 1 and 2, 10 mg
of each indicated plasmid were cotransfected; lanes 3–8, 5 mg of each of the two donor plasmids and 10 mg of the pWHV-e-2 recipient plasmid
were cotransfected. (E) Heterologous complementation of encapsidation functions. 5 mg of each of the two donor plasmids and 10 mg of the pE-
LacZ recipient plasmid were cotransfected as indicated above the lanes. In (A)–(E), lanes 1, 3, 5, 7, total poly(A)/ selected RNA; lanes 2, 4, 6, 8,
RNA isolated from purified cytoplasmic cores. The major band in all lanes corresponds to a e-lacZ chimeric RNA molecule of approximately 3.5 kb
in length.
possibility that polymerase and capsid proteins interact This led us to investigate whether there is indeed a
virus-specific interaction of capsid and polymerase pro-with each other in a virus-specific manner, since the HBV
polymerase–HBV RNA complexes that were presumably teins. To address this question we first had to construct
separate expression plasmids for HBV (and WHV) capsidformed were not detected as encapsidated HBV DNA
molecules in the released viral progeny. Hepadnaviral and polymerase proteins and demonstrate homologous
complementation of these proteins. Once this was estab-polymerase has been shown to preferentially bind to its
own mRNA (Bartenschlager et al., 1990; Hirsch et al., lished we could then transfect HepG2 cells with plasmids
expressing HBV capsid and WHV polymerase and vice1990; Junker-Niepmann et al., 1990; Hirsch et al., 1991).
Therefore, in that experiment it was possible that the versa and ask whether encapsidation takes place. As
HBV capsid donors, we constructed plasmids pHBV-C1efficient formation of WHV polymerase–HBV pregenome
complexes was prevented due to competitive binding by and pHBV-C2 (Fig. 1A) which carry mutations in either the
5*- (pHBV-C1) or 3*- (pHBV-C2) region of the polymerasefunctional HBV polymerase.
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gene. In the HBV polymerase donor plasmid pHBV-P University of Wisconsin Genetics Computer Group se-
quence analysis programs (Genetics Computer Group,(Fig. 1A), the 5*-region of the core open reading frame
is deleted, while the polymerase gene remains intact. 1994), capsid and polymerase proteins of HBVadw2 and
WH81 exhibit an identity score of 66.5% (77.8% similarity)Similar plasmids were constructed derived from pWHV-
CP (all of which are presented schematically in Fig. 1A): and 53.8% (69.1% similarity), respectively. How then can
one account for the earlier result that no HBV genomespWHV-C1 and pWHV-C2 are WHV capsid donors, and
WHV polymerase donor plasmid pWHV-P carries a muta- were identified when HepG2 cells were cotransfected
with plasmids harboring dimers of core-negative HBVtion in the core gene. Figure 4A shows that neither trans-
fection with pHBV-C1 (lanes 3 and 4) nor pHBV-P (lanes and wild-type WHV genomes? Since our data indicate
no block to heterologous RNA packaging, the block ob-5 and 6) alone will lead to encapsidation of the message
transcribed from pE-LacZ, but when both plasmids are served by Okamoto et al. (1990) would have to be distal
to this step.cotransfected with pE-LacZ (lanes 7 and 8), HBV capsid
and polymerase complement each other in trans and We therefore asked whether HBV pregenomic RNA
encapsidated by HBV capsid and WHV polymerase pro-RNA packaging ensues, although slightly less efficiently
than in the control transfection of pHBV-CP with pE-LacZ teins could be successfully reverse transcribed. For this
purpose, we constructed a 1.5-mer HBV plasmid bearing(lanes 1 and 2). To exclude the possibility that site-spe-
cific recombination among the capsid and polymerase a polymerase-negative mutation and cotransfected it with
either pHBV-P or pWHV-P; following transfection, viraldonor plasmids restored a plasmid with wild-type se-
quences we cotransfected HepG2 cells with pHBV-C1 RNA packaging and DNA synthesis were scored. In this
experiment (data not shown) viral DNA synthesis by het-and pHBV-C2 plus pWHV-e-2. It was demonstrated pre-
viously by Schaller and Radziwill (1990) that HBV poly- erologous polymerase protein, after normalization for the
efficiency of RNA packaging, proceeded with nearly themerase proteins harboring mutations in different enzy-
matic domains can not trans-complement each other in- same efficiency as that mediated by the homologous
polymerase. We therefore cannot ascribe the result oftragenically. As anticipated, neither pHBV-C2 (Fig. 4B,
lanes 1 and 2) nor pHBV-C1 plus pHBV-C2 (lanes 3 and Okamoto et al. (1990) to impaired DNA synthesis; con-
ceivably, it could relate to inefficient envelopment and4) gave positive results when cotransfected with pWHV-
e-2, while pHBV-C2 efficiently complements pHBV-P in export of heterologous cores.
The ready complementation of HBV and WHV capsidRNA encapsidation function (lanes 5 and 6).
Comparable results were obtained with the WHV-de- and polymerase proteins implies that attempts to define
specific domains governing the capsid-polymerase inter-rived plasmids in a similar set of transfection experi-
ments (documented in Figs. 4C and 4D). Complementa- action by studying HBV/WHV chimeric capsid or polymer-
ase proteins will not be possible. It is likely that a fulltion of WHV capsid and polymerase functions presented
in lanes 7 and 8 of Fig. 4C (using pWHV-C1 and pWHV- understanding of these interactions will require develop-
ment of an in vitro packaging and envelopment system;P as donor plasmids), and in lanes 5 and 6 of Fig. 4D
(using pWHV-C2 and pWHV-P), proceeded as efficiently such efforts are now under way.
as the homologous interactions in HBV.
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